|
Improving Health Services for Veterans with Schizophrenia Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Improving Health Services for Veterans with Schizophrenia conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Improving Health Services for Veterans with Schizophrenia Clinical research trials and Improving Health Services for Veterans with Schizophrenia healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Improving Health Services for Veterans with Schizophrenia. Improving Health Services for Veterans with Schizophrenia Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Improving Health Services for Veterans with Schizophrenia clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Improving Health Services for Veterans with Schizophrenia condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Improving Health Services for Veterans with Schizophrenia  Improving Health Services for Veterans with Schizophrenia
Improving Health Services for Veterans with Schizophrenia
For Condition: Schizophrenia
Status: Recruiting
Sponsor(s): Department of Veterans Affairs , Department of Veterans Affairs Health Services Research and Development Service,University of Maryland
Synopsis: Schizophrenia is a serious, often chronically disabling mental illness that affects about one percent of the general population and exacts high costs. There is substantial evidence that many patients with schizophrenia, including veterans, do not receive treatment that is consistent with existing, empirically proven treatment technologies. The objectives of this study are: 1) to conduct a field trial of methods for assessing the quality of care (QOC) provided to patients with schizophrenia in a unified system of care, VISN 5; 2) to test hypotheses linking provider adherence with the Patient Outcomes Research Team (PORT) treatment recommendations to: (a) patterns of service utilization; and (b) outcomes, in order to assess the validity of the treatment recommendations as QOC standards; 3) to determine the patient characteristics that correlate with adherence to the PORT treatment recommendations; and 4) to estimate the direct treatment costs associated with adherence and non-adherence to the PORT treatment recommendations. Prospective patterns of service utilization, content of care, and outcomes are being assessed for a ten percent random sample (n=300) of all outpatients in VISN 5 with an Axis I schizophrenia spectrum disorder diagnosis, who will complete baseline and six-month follow up outcome assessments. One-year retrospective and six-month prospective patterns of service utilization and treatment recommendation adherence will also be determined using information obtained from administrative databases, medical record review, and patient report.
Details:
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Random Sample, Prospective Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Patients must be adults currently in treatment for an Axis I schizophrenia spectrum disorder (DSM295) at VA.
Total Enrollment: 300
Location and Contact Information:
VA Maryland Health Care System *Recruiting*
Baltimore, Maryland, 21201
United States
Recruiting Alan Bellack 410-605-7383
Additional Information:
Study ID Numbers: VCR 99-012;
Study Start Date: April 2000
Record last reviewed: December 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00012961
Other Schizophrenia Studies:
1. Olanzapine Versus Active Comparator in the Treatment of Depression in Patients with Schizophrenia
2. Rehabilitative Training for Older People with Schizophrenia
3. Medication Adherence in Older People with Psychosis
4. To Determine If Olanzapine Is More Cost Effective Than Haloperidol for the Treatment of Schizophrenia
5. Open label trial exploring a switch from oral medications, to risperidone depot microspheres
Related Studies:
Other Schizophrenia Clinical Trials
Other Maryland Clinical Trials
Other Baltimore Clinical Trials
Improving Health Services for Veterans with Schizophrenia
|
|
|
|
|
|
|
|
